Novel Monoclonal Anitbody and Use thereof
    1.
    发明申请
    Novel Monoclonal Anitbody and Use thereof 审中-公开
    新型单克隆抗体及其用途

    公开(公告)号:US20090263840A1

    公开(公告)日:2009-10-22

    申请号:US11992008

    申请日:2006-09-14

    IPC分类号: G01N33/53 C07K16/00

    摘要: The present invention provides an antibody capable of specifically recognizing the same amino acid sequence as an antigenic determinant of mouse monoclonal antibody MAB-ME-16F4.3 (FERM BP-10329), and an antibody of capable of specifically recognizing the same amino acid sequence as an antigenic determinant of mouse monoclonal antibody MAB-ME-12C9.2 (FERM BP-10328), and methods of risk prediction of bone fracture and/or diagnosis of osteoporosis by detecting a MEPE-derived molecule in a biological sample using the above-mentioned two kinds of antibodies.

    摘要翻译: 本发明提供能够特异性识别与小鼠单克隆抗体MAB-ME-16F4.3(FERM BP-10329)的抗原决定簇相同的氨基酸序列的抗体,以及能够特异性识别相同氨基酸序列的抗体 作为小鼠单克隆抗体MAB-ME-12C9.2(FERM BP-10328)的抗原决定簇,以及通过使用上述检测生物样品中的MEPE衍生的分子检测骨折和/或骨质疏松症诊断的风险预测方法 所述两种抗体。